Methyl 2,5-dihydroxycinnamate
CAS: 63177-57-1
Rif. 3D-FM25380
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione |
Informazioni sul prodotto
- 3-(2,5-Dihydroxyphenyl)-2-propenoic Acid Methyl Ester
- 2,4-Dihydroxymethylcinnamate
- 2,5-Dihydroxycinnamic acid methyl ester
- Methyl 3-(2,5-dihydroxyphenyl)-2-propenoate
- 2-Propenoic acid, 3-(2,5-dihydroxyphenyl)-, methyl ester
- methyl (2E)-3-(2,5-dihydroxyphenyl)prop-2-enoate
Methyl 2,5-dihydroxycinnamate is a tyrosine kinase inhibitor that is used in the treatment of squamous cell carcinoma. It has been shown to inhibit the phosphorylation of tyrosine and protein kinase C (PKC) activity in HL-60 cells. This inhibition leads to the inhibition of signal pathways, such as those initiated by epidermal growth factor (EGF), transforming growth factor beta (TGF-β), and platelet-derived growth factor (PDGF). Methyl 2,5-dihydroxycinnamate also inhibits PGE2 levels in hemocytes from ascidian larvae.